This Stock Could Make You Rich

History proves that, while low-priced businesses can make for good returns, reasonably priced great businesses can make you rich.

By "great businesses," I mean those that are growing fast in important industries. These are the millionaire makers, emerging multibaggers that dour analysts often proclaim as overpriced but which produce massive returns on invested capital. Some winners that you might recognize:

Company

Recent Price

5-Year Revenue Growth

ROIC

5-Year Return

Intuitive Surgical (Nasdaq: ISRG  )

$107.27

57.0%

16.0%

494.9%

Quality Systems (Nasdaq: QSII  )

$39.29

28.0%

33.4%

260.1%

Oceaneering International (NYSE: OII  )

$30.61

25.8%

16.0%

88.9%

Sources: Motley Fool CAPS, Capital IQ, a division of Standard & Poor's, and Yahoo! Finance.

Outsized growth is what made investors in these stocks rich. These stocks were worth paying for, as the best almost always are -- high P/E multiples be damned.

Investors have always placed far too much faith in the shorthand of multiples. We don't recognize that a stock trading for more than 100 times earnings can be cheap, as Celgene (Nasdaq: CELG  ) was in 2004, before it quintupled. And we forget that Green Mountain Coffee Roasters (Nasdaq: GMCR  ) , one of the 10 best stocks of the past decade, traded for as much as 76 times earnings in 1999.

Why? Of the 317 stocks listed on major U.S. exchanges that recorded a positive return last year, 53 entered the year trading for more than 30 times earnings, including Eldorado Gold (NYSE: EGO  ) .

What's more, Foolish co-founder David Gardner frequently selects great businesses at reasonable prices for our Motley Fool Rule Breakers service and for his Motley Fool CAPS portfolio. CAPS is a 125,000-strong stock picking community; David's picks rank him in the top 2% of investors there.

Hunting for the next millionaire-maker
So if paying up for growth works, why not do it more often? I suppose because doing so poses risks. Overpriced growers can fall faster than their (ahem) "cheaper" peers. Plus, betting on growth alone is dangerous -- any company can enjoy a short burst of unexpected success.

We want to pay up for businesses that are positioned for long-term growth -- firms that already have a history of high growth, are expected to maintain that pace for at least the next two years, and produce above-average returns on capital.

So, using those characteristics, I ran a screen at Capital IQ that returned 109 potential winners. My favorite of the list will surprise no one: Apple (Nasdaq: AAPL  ) , which has a massive following in our CAPS community:

Metric

Apple

CAPS stars (5 max)

****

Total ratings

21,399

Percent Bulls

92.1%

Percent Bears

7.9%

Bullish pitches

4,275 of 4,752

Data current as of Feb. 17, 2009.

The bulls have many reasons to snort. The Apple Store is one of the most successful retail ideas ever. The iPhone was the top U.S. handset in the third quarter last year. And Macs continue to gain market share.

"How can I not weigh in on the most-rated stock on CAPS? You definitely have to pay a premium to ride the [Apple] train, but with the strength of the brand and products right now I'd rather be on that train than in front of it," wrote Foolish colleague Matt Koppenheffer, a.k.a. TMFKopp, yesterday.

Me too. After suffering through a harsh January during which CEO Steve Jobs announced a six-month medical leave, shares of Apple have surged 20% off their lows. But I see room for further gains. After all, more than 30% of the iEmpire's market value is denominated in cash and liquid investments.

Do you agree? Disagree? Let us know by signing up for CAPS today. It's 100% free to participate.

See you back here in two weeks with another potential millionaire-maker. Fool on!

Fool contributor Tim Beyers also contributes to the market-beating Rule Breakers service. Apple and Quality Systems are Stock Advisor selections. Intuitive Surgical is a Rule Breakers pick.

Tim had stock and options positions in Apple at the time of publication. Check out his portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. The Motley Fool is also on Twitter as @TheMotleyFool. Its disclosure policy has been living richly for the past 15 years.


Read/Post Comments (1) | Recommend This Article (19)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 19, 2009, at 12:07 PM, PauvrePapillon wrote:

    If you’re looking for stocks that could make you rich, why not take a look at Accuray?

    When the market (correctly) understood that CyberKnife was a truly unique and revolutionary technology, investors bid Accuray’s post-IPO shares up to an intraday high of $31.09 (9 February 2007). As Varian and others made repeated claims, in numerous press releases, interviews and conference calls, that their gantry-mounted machines could do the same thing as the robotically controlled CyberKnife, Accuray’s market cap shrank even though its economic fundamentals actually improved.

    On 6 December 2008, Accuray, finally, fired back with the release of two animated videos that effectively demonstrate what CyberKnife is and why it is fundamentally different from gantry-mounted radiation sprayers. You can see them for yourself at http://www.accuray.com.

    Since then, Accuray shares have gone up 27 percent (as of close of market Wednesday 19 February 2009) while Varian’s shares have gone down nine percent while Tomo is down 20 percent and ISRG is down 22 percent against the backdrop of a NASDAQ index that has lost three percent.

    Are investors now beginning to rethink this space and conclude that Accuray really does have something?

    From Breakthroughs That Will Change Lives in 2009…

    “Cyberknife has the potential to replace surgery as the first form of treatment for cancer,” says Dr Nick Plowman, director of clinical oncology at St Bartholomew's Hospital.

    http://www.dailymail.co.uk/health/article-1106224/From-machi...

    Is CyberKnife just now being discovered by, and moving into, a huge market?

    See WSJ’s Is CyberKnife Ready for Prime Time in Prostate Cancer?

    http://blogs.wsj.com/health/2008/11/28/is-cyberknife-ready-f...

    And it’s making waves in Europe and Asia as well…

    From ABC News London…

    http://www.abcnews.go.com/Video/playerIndex?id=6549791

    And most CAPS players like it…

    http://caps.fool.com/Ticker/ARAY.aspx

    You might still be able to make some money with Intuitive Surgical but with Accuray you have a serious candidate for a multi-bagger in the making whose underlying technology is still in the early stages of its adoption curve. Peter Lynch would be all over this one.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 834200, ~/Articles/ArticleHandler.aspx, 9/2/2014 10:24:42 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement